O'Neil Global Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-570
Closed -$235K 75
2024
Q2
$235K Buy
570
+19
+3% +$7.52K 0.11% 41
2024
Q1
$223K Sell
551
-144
-21% -$50.6K 0.28% 32
2023
Q4
$213K Buy
+695
New +$188K 0.12% 49
2023
Q3
Sell
-1,065
Closed -$256K 82
2023
Q2
$256K Buy
+1,065
New +$221K 0.05% 71
2023
Q1
Sell
-5,322
Closed -$1.13M 80
2022
Q4
$1.13M Buy
+5,322
New +$1.06M 5.22% 4

Other funds holding MEDP

O'Neil Global Advisors's MEDP Position: Q3 2024 in Review

O'Neil Global Advisors sold out of Medpace (MEDP) in Q3 2024, closing a stake of 570 shares — an estimated $235K sold.

O'Neil Global Advisors first reported a position in MEDP in Q4 2022 and held it in 5 quarters. The position peaked at $1.13M in Q4 2022. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • O'Neil Global Advisors reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • O'Neil Global Advisors sold 570 Medpace shares in Q3 2024, an estimated $235K.
  • O'Neil Global Advisors first reported a position in Medpace in Q4 2022 and held it in 5 quarters.
  • O'Neil Global Advisors's Medpace position peaked at $1.13M in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on O'Neil Global Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.